BNTCBenitec Biopharma Inc.

$8.74-37% 1Y
Latest close: a new 52-week lowOct 8, 2026what changed →

The financials

Benitec Biopharma Inc. by the numbers

The next results filing is expected around Dec 14, 2026, a quarter after the last one.

Benitec Biopharma Inc. income statement, Q4 2026 against the same quarter a year earlier
Income statementQ4 2026Q4 2025Change
Operating income−$14M−$9.8Mn/a
Net income−$13M−$8.8Mn/a
Diluted EPS−$0.26−$0.21n/a